|
04.03.2009 14:00:00
|
Phase Forward to Participate in Key March Events
Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, will participate in three upcoming industry events: Association for Clinical Data Management (ACDM), DIA Data Conference and Exhibition and DIA EuroMeeting. Details are as follows:
At the ACDM conference, March 9-10, in Northamptonshire, U.K., Phase Forward will participate in three sessions:
|
Who: Rob Nichols, Director, Commercial Development, Phase Forward (Session Chair) |
|
|
What: "MHRA Audits” breakout session |
|
|
When: Monday, March 9, 11:45 a.m.-12:45 p.m. local time |
|
|
Who: Adrian Foulkes, Director, Clinical Services, Phase Forward (Debater) |
|
|
What: Debate: "This House Believes That the Huge Advances in Technology Have Not Led to Any Significant Increase in the Quality of Data” |
|
|
When: Tuesday, March 10, 9:45 a.m.-10:30 a.m. local time |
|
|
Who: Paul Millard, Training Manager, Phase Forward (Presenter) |
|
|
What: "Electronic Data Capture + Effective Training = High Quality Data” |
|
|
When: Tuesday, March 10, 2:00-2:30 p.m. local time |
At the DIA Data Conference and Exhibition, March 9-11, in Philadelphia, PA, Phase Forward will participate in two sessions:
|
Who: Mike Davies, Vice President, Global CRO Partnerships, Phase Forward (Panelist) |
|
|
What: "How CROs and EDC Providers Are Partnering to Deliver 3-Technologies in Large, Global Studies” |
|
|
When: Tuesday, March 10, 3:30-5:00 p.m. local time |
|
|
Who: Tim Rochford, Chief Technical Officer, Phase Forward and Wayne Kubick, Senior Vice President, Phase Forward Lincoln Safety Group (Panelists) |
|
|
What: "Clinical Research Repositories as a Collaboration Platform” and "Perspectives on Data Repositories using SDTM, Janus and HL7” |
|
|
When: Wednesday, March 11, 3:30-5:00 p.m. local time |
At the DIA EuroMeeting, March 23-25, in Berlin, Germany, Phase Forward will participate in one session:
|
Who: Laurence Charonnat, Principal Project Manager, Phase Forward S.A.S., France (Presenter) |
|
|
What: "Adopting EDC – The Importance of Project Management” |
|
|
When: Tuesday, March 24, 2:00-3:30 p.m. local time |
Members of the media interested in speaking with Phase Forward at the DIA Data Conference and Exhibition conference should contact Meghan Locke at 781-672-3147 or mlocke@chenpr.com. For ADCM and the DIA EuroMeeting, members of the media should contact Maria Sumner at +44 1628 640743 or maria.sumner@phaseforward.com.
About Phase Forward
Phase Forward is a leading provider of integrated data management solutions for clinical trials and drug safety. The company offers proven solutions for electronic data capture (InForm™), phase I clinic automation (LabPas™), clinical data management (Clintrial™), clinical trials signal detection (CTSD™), strategic pharmacovigilance (Empirica Signal™) and Signal Management, adverse event reporting (Empirica Trace™), applied data standards (WebSDM™) and Web-integrated interactive response technologies (Clarix™). In addition, the company provides services in the areas of application implementation, hosting and validation, data integration, business process optimization, safety data management and industry standards. Phase Forward’s products and services have been utilized in over 10,000 clinical trials involving more than 1,000,000 clinical trial study participants at over 280 organizations and regulatory agencies worldwide including: AstraZeneca, Boston Scientific, Dana-Farber Cancer Institute, Eli Lilly, the U.S. Food and Drug Administration, GlaxoSmithKline, Harvard Clinical Research Institute, Merck Serono, Novartis, Novo Nordisk, PAREXEL International, Procter & Gamble, Quintiles, sanofi-aventis, Schering-Plough Research Institute, Servier, Tibotec and the U.K. Medicines and Healthcare Products Regulatory Agency. Additional information about Phase Forward is available at www.phaseforward.com.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Oracle Corp.mehr Nachrichten
|
28.01.25 |
NASDAQ Composite Index-Wert Oracle-Aktie: So viel Gewinn hätte ein Oracle-Investment von vor 5 Jahren abgeworfen (finanzen.at) | |
|
27.01.25 |
Handel in New York: S&P 500 in Rot (finanzen.at) | |
|
24.01.25 |
Musk kritisiert Trumps KI-Pläne - Softbank- und Oracle-Aktien schwächer (dpa-AFX) | |
|
22.01.25 |
Gewinne in New York: Am Nachmittag Gewinne im NASDAQ Composite (finanzen.at) | |
|
22.01.25 |
Optimismus in New York: NASDAQ Composite bewegt sich am Mittwochmittag im Plus (finanzen.at) | |
|
22.01.25 |
AKTIEN IM FOKUS 3: KI-Fantasie bei Siemens Energy, Hochtief, Oracle und mehr (dpa-AFX) | |
|
22.01.25 |
Aufschläge in New York: NASDAQ Composite beginnt Handel mit Gewinnen (finanzen.at) | |
|
22.01.25 |
AKTIEN IM FOKUS 2: Rechenzentren-Fantasie bei Siemens Energy, Hochtief & Oracle (dpa-AFX) |
Analysen zu Oracle Corp.mehr Analysen
| 27.01.25 | Oracle Buy | Jefferies & Company Inc. | |
| 03.01.25 | Oracle Sector Perform | RBC Capital Markets | |
| 10.12.24 | Oracle Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 10.12.24 | Oracle Sector Perform | RBC Capital Markets | |
| 10.12.24 | Oracle Neutral | JP Morgan Chase & Co. |
Aktien in diesem Artikel
| Oracle Corp. | 163,04 | -0,60% |
|
Indizes in diesem Artikel
| NASDAQ Comp. | 19 627,44 | -0,28% |
Letzte Top-Ranking Nachrichten
Nachrichten
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.